NCT00197184View on ClinicalTrials.gov

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

November 1, 2003

Primary Completion Date

March 10, 2004

Study Completion Date

March 10, 2004

Conditions
Hepatitis BHepatitis A
Interventions
BIOLOGICAL

Twinrix™ Adult

Intramuscular injection in the left deltoid, 2 doses, Adult formulation in primary study.

BIOLOGICAL

Twinrix™ Junior

Intramuscular injection in the left deltoid, 3 doses, junior formulation in primary study.

Trial Locations (7)

1200

GSK Investigational Site, Brussels

3053

GSK Investigational Site, Carlton

5006

GSK Investigational Site, North Adelaide

17300

GSK Investigational Site, Blanes (Girona)

46024

GSK Investigational Site, Valencia

08042

GSK Investigational Site, Barcelona

08290

GSK Investigational Site, Cerdanyola Del Vallés / Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY